Logo-jhp
J Herbmed Pharmacol. 2021;10(4): 443-458. doi: 10.34172/jhp.2021.52

Original Article

Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies

Rehab Fikry Taher 1 * ORCID, Ahmed A. Al-Karmalawy 2 ORCID, Ahmed I. Abd El Maksoud 3 ORCID, Hany Khalil 4 ORCID, Amr Hassan 5 ORCID, Ezzel-Din A. El-Khrisy 1 ORCID, Walaa El-Kashak 1 ORCID

Cited by CrossRef: 40

1- Abo Elmaaty A, Al‐Karmalawy A, Nafie M, Shamaa M, Zaki I, Alnajjar R, Zakaria M. Experimental design of D-α-tocopherol polyethylene glycol 1000 succinate stabilized bile salt based Nano-vesicles for improved cytotoxicity and bioavailability of colchicine binding site inhibitor Candidates: In Vitro, in silico, and pharmacokinetic studies. International Journal of Pharmaceutics. 2023;640:122980 [Crossref]
2- El-Azab M, Al-Karmalawy A, Antar S, Hanna P, Tawfik K, Hazem R. A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways. Life Sciences. 2022;303:120691 [Crossref]
3- Abo Elmaaty A, Eldehna W, Khattab M, Kutkat O, Alnajjar R, El-Taweel A, Al-Rashood S, Abourehab M, Binjubair F, Saleh M, Belal A, Al-Karmalawy A. Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies. IJMS. 2022;23(20):12235 [Crossref]
4- Shaaban S, Al-Karmalawy A, G. Alhamzani A, Abou–Krisha M, Al–Qudah M, Yousef T. Synthesis and Molecular Docking Analysis of New Thiazo-isoindolinedione Hybrids as Potential Inhibitors of the SARS-CoV-2 Main Protease. Orient J Chem. 2023;39(4):913 [Crossref]
5- Al-Karmalawy A, Mousa M, Sharaky M, Mourad M, El-Dessouki A, Hamouda A, Alnajjar R, Ayed A, Shaldam M, Tawfik H. Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. J Med Chem. 2024;67(1):492 [Crossref]
6- Abdelrahman N, Al-Karmalawy A, Jaballah M, Yahya G, Sharaky M, Abouzid K. Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy. RSC Med Chem. 2024;15(3):981 [Crossref]
7- Elebeedy D, Badawy I, Elmaaty A, Saleh M, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Abd El Maksoud A, Al-karmalawy A. In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus. Computers in Biology and Medicine. 2022;141:105149 [Crossref]
8- El-Masry R, Al-Karmalawy A, Alnajjar R, Mahmoud S, Mostafa A, Kadry H, Abou-Seri S, Taher A. Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies. New J Chem. 2022;46(11):5078 [Crossref]
9- Elmaaty A, Darwish K, Chrouda A, Boseila A, Tantawy M, Elhady S, Shaik A, Mustafa M, Al-karmalawy A. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. ACS Omega. 2022;7(1):875 [Crossref]
10- Ahmed S, Kamel M, Aboelez M, Ma X, Al-Karmalawy A, Mousa S, Shokr E, Abdel-Ghany H, Belal A, El Hamd M, Al Shehri Z, El Aleem Ali Ali El-Remaily M. Thieno[2,3-b]thiophene Derivatives as Potential EGFRWT and EGFRT790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies. ACS Omega. 2022;7(49):45535 [Crossref]
11- Al-Muntaser S, Al-Karmalawy A, El-Naggar A, Ali A, Abd El-Sattar N, Abbass E. Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies. RSC Adv. 2023;13(18):12184 [Crossref]
12- Ibrahim R, Abdel-Baki P, Mohamed O, Al-Karmalawy A, Tripathi A, El-Shiekh R. Metabolites profiling, in-vitro and molecular docking studies of five legume seeds for Alzheimer’s disease. Sci Rep. 2024;14(1) [Crossref]
13- Dabous E, Alalem M, Awad A, Elawdan K, Tabl A, Elsaka S, Said W, Guirgis A, Khalil H. Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells. BMC Cancer. 2024;24(1) [Crossref]
14- Hammoud M, Khattab M, Abdel-Motaal M, Van der Eycken J, Alnajjar R, Abulkhair H, Al‐Karmalawy A. Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity. Journal of Biomolecular Structure and Dynamics. 2022;:1 [Crossref]
15- Fekry T, Salem M, Abd-Elaziz A, Muawia S, Naguib Y, Khalil H. Anticancer Properties of Selenium-Enriched Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), in Colon Cancer In Vitro . Int J Med Mushrooms. 2022;24(11):1 [Crossref]
16- Hammoud M, Nageeb A, Morsi M, Gomaa E, Elmaaty A, Al-Karmalawy A. Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers. New J Chem. 2022;46(23):11422 [Crossref]
17- Al-Karmalawy A, Alnajjar R, Elmaaty A, Binjubair F, Al-Rashood S, Mansour B, Elkamhawy A, Eldehna W, Mansour K. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile ; in silico and in Vitro assessments with structure-activity relationship . Journal of Biomolecular Structure and Dynamics. 2024;42(13):6941 [Crossref]
18- Hamed A, El-Shiekh R, Mohamed O, Aboutabl E, Fathy F, Fawzy G, Al-Taweel A, Elsayed T, Tripathi A, Al-Karmalawy A. Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking. Molecules. 2023;28(6):2559 [Crossref]
19- Hammouda M, Elmaaty A, Nafie M, Abdel-Motaal M, Mohamed N, Tantawy M, Belal A, Alnajjar R, Eldehna W, Al‐Karmalawy A. Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies. Bioorganic Chemistry. 2022;127:105995 [Crossref]
20- Abd-Alla H, Kutkat O, Sweelam H, Eldehna W, Mostafa M, Ibrahim M, Moatasim Y, GabAllah M, Al-Karmalawy A. Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies. Metabolites. 2022;12(11):1109 [Crossref]
21- Raghunath Khedkar N, Sindkhedkar M, Joseph A. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFRWT and EGFRT790M with ADMET Profiling. Bioorganic Chemistry. 2024;143:107027 [Crossref]
22- Shahin I, Mohamed K, Taher A, Elsebaei M, Mayhoub A, Kassab A, Elshewy A. New Phenylthiazoles: Design, Synthesis, and Biological Evaluation as Antibacterial, Antifungal, and Anti‐COVID‐19 Candidates. Chemistry & Biodiversity. 2023;20(11) [Crossref]
23- Al-Karmalawy A, Farid M, Mostafa A, Ragheb A, H. Mahmoud S, Shehata M, Shama N, GabAllah M, Mostafa-Hedeab G, Marzouk M. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2. Molecules. 2021;26(21):6559 [Crossref]
24- Al-Karmalawy A, Nafie M, Shaldam M, Elmaaty A, Antar S, El-Hamaky A, Saleh M, Elkamhawy A, Tawfik H. Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. J Med Chem. 2023;66(1):777 [Crossref]
25- Ezz Eldin R, Saleh M, Alotaibi M, Alsuair R, Alzahrani Y, Alshehri F, Mohamed A, Hafez S, Althoqapy A, Khirala S, Amin M, A. F Y, AbdElwahab A, Alesawy M, Elmaaty A, Al-Karmalawy A. Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 2022;37(1):1098 [Crossref]
26- Ghanem A, Al-Karmalawy A, Abd El Maksoud A, Hanafy S, Emara H, Saleh R, Elshal M. Rumex Vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression. Informatics in Medicine Unlocked. 2022;29:100869 [Crossref]
27- Farouk F, Elmaaty A, Elkamhawy A, Tawfik H, Alnajjar R, Abourehab M, Saleh M, Eldehna W, Al‐Karmalawy A. Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies . Journal of Enzyme Inhibition and Medicinal Chemistry. 2023;38(1) [Crossref]
28- Salem M, Mohamed O, Mosalam E, Elberri A, Abdel-Bar H, Hassan M, Al-Karmalawy A, Tripathi A, Ezzat S, Abo Mansour H. Investigation of the phytochemical composition, antioxidant, antibacterial, anti-osteoarthritis, and wound healing activities of selected vegetable waste. Sci Rep. 2023;13(1) [Crossref]
29- Gaber A, Sharaky M, Elmaaty A, Hammouda M, Mourad A, Elkhawaga S, Mokhtar M, Abouzied A, Mourad M, Al-Karmalawy A. Design and Synthesis of Novel Pyrazolopyrimidine Candidates As Promising EGFR-T790M Inhibitors and Apoptosis Inducers. Future Med Chem. 2023;15(19):1773 [Crossref]
30- Elawdan K, Farouk S, Aref S, Shoaib H, El-Razik M, Abbas N, Younis M, Alshambky A, Khalil H. Association Of Vitamin B12/Ferritin Deficiency In Cancer Patients with Methylomic Changes At Promotors of TET  Methylcytosine Dioxygenases . Biomark Med. 2022;16(13):959 [Crossref]
31- Shalaby A, Eid H, El-Shiekh R, Mohamed O, Tripathi A, Al-Karmalawy A, Sleem A, Morsy F, Ibrahim K, Tadros S, Youssef F. Taming Food–Drug Interaction Risk: Potential Inhibitory Effects of Citrus Juices on Cytochrome Liver Enzymes Can Safeguard the Liver from Overdose Paracetamol-Induced Hepatotoxicity. ACS Omega. 2023;8(29):26444 [Crossref]
32- Zakaria M, Sharaky M, Noreddin A, Alnajjar R, EL-Shesheny R, Kutkat O, El‐Beeh M, Abourehab M, Al-Karmalawy A. Investigating the superiority of chitosan/D-alpha-tocopheryl polyethylene glycol succinate binary coated bilosomes in promoting the cellular uptake and anti-SARS-CoV-2 activity of polyphenolic herbal drug candidate. International Journal of Pharmaceutics. 2023;646:123385 [Crossref]
33- Alalem M, Dabous E, Awad A, Alalem N, Guirgis A, El-Masry S, Khalil H. Influenza a virus regulates interferon signaling and its associated genes; MxA and STAT3 by cellular miR-141 to ensure viral replication. Virol J. 2023;20(1) [Crossref]
34- Fawzy R, Abdel-Aziz A, Bassiouny K, Fayed A. Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line. Journal of Genetic Engineering and Biotechnology. 2024;22(1):100339 [Crossref]
35- Madbouly E, Lashine E, Al-Karmalawy A, Sebaiy M, Pratsinis H, Kletsas D, Metwally K. Design and synthesis of novel quinazolinone–chalcone hybrids as potential apoptotic candidates targeting caspase-3 and PARP-1:in vitro, molecular docking, and SAR studies. New J Chem. 2022;46(46):22013 [Crossref]
36- Elagawany M, Elmaaty A, Mostafa A, Abo Shama N, Santali E, Elgendy B, Al-Karmalawy A. Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry. 2022;37(1):2112 [Crossref]
37- Hassan A, Al-Salmi F, Abuamara T, Matar E, Amer M, Fayed E, Hablas M, Mohammed T, Ali H, Abd EL-fattah F, Abd Elhay W, Zoair M, Mohamed A, Sharaf E, Dessoky E, Alharthi F, Althagafi H, Abd El Maksoud A. Ultrastructural analysis of zinc oxide nanospheres enhances anti-tumor efficacy against Hepatoma. Front Oncol. 2022;12 [Crossref]
38- Shalaby A, Eid H, El‐Shiekh R, Youssef F, Al‐Karmalawy A, Farag N, Sleem A, Morsy F, Ibrahim K, Tadros S. A Comparative GC/MS Analysis of Citrus Essential Oils: Unveiling the Potential Benefits of Herb‐Drug Interactions in Preventing Paracetamol‐Induced Hepatotoxicity. Chemistry & Biodiversity. 2023;20(9) [Crossref]
39- El-Naggar A, Hassan A, Elkaeed E, Alesawy M, Al‐Karmalawy A. Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2. Bioorganic Chemistry. 2022;123:105770 [Crossref]
40- Al-Warhi T, Al-Karmalawy A, Elmaaty A, Alshubramy M, Abdel-Motaal M, Majrashi T, Asem M, Nabil A, Eldehna W, Sharaky M. Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors . Journal of Enzyme Inhibition and Medicinal Chemistry. 2023;38(1):176 [Crossref]
41- Veeramuthu K, Ahuja V, Annadurai P, Gideon D, Sundarrajan B, Rusu M, Annadurai V, Dhandayuthapani K. Chemical Profiling and Biological Activity of Psydrax dicoccos Gaertn. Molecules. 2023;28(20):7101 [Crossref]
42- Diab R, Abdel-Sami Z, Abdel-Aal E, Al-Karmalawy A, Abo-Dya N. Design and synthesis of a new series of 3,5-disubstituted-1,2,4-oxadiazoles as potential colchicine binding site inhibitors: antiproliferative activity, molecular docking, and SAR studies. New J Chem. 2021;45(46):21657 [Crossref]